• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (110)

    Publication numberPublication dateAssigneeTitle
    US-5571498-ANovember 05, 1996Hemagen/PfcEmulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI).
    US-2007003479-A1January 04, 2007Epix Pharmaceuticals, Inc., A Delaware CorporationDiagnostic imaging contrast agents with extended blood retention
    US-5250284-AOctober 05, 1993Arnon KrongradMethod for increasing nuclear magnetic resonance signals in living biological tissue using zinc
    US-5466438-ANovember 14, 1995Imarx Pharmaceutical Corp.Liposoluble compounds useful as magnetic resonance imaging agents
    US-5362476-ANovember 08, 1994Board Of Regents, The University Of Texas System, Dow Chemical CompanyAlkyl phosphonate polyazamacrocyclic cheates for MRI
    US-5681543-AOctober 28, 1997Shering AktiengesellschaftPolymer-bonded complexing agents and pharmaceutical agents containing them for MRI
    US-5911971-AJune 15, 1999Schering AktiengesellschaftCascade polymer bound complexing compounds for MRI
    US-6010682-AJanuary 04, 2000Imarx Pharmaceuticals Corp.Liposoluble compounds useful as magnetic resonance imaging agents
    US-5312617-AMay 17, 1994Unger Evan C, Shen DekangLiposoluble compounds useful as magnetic resonance imaging agents
    US-5422096-AJune 06, 1995The General Hospital CorporationHydroxy-aryl metal chelates for diagnostic NMR imaging
    US-5739294-AApril 14, 1998The Dow Chemical CompanyBicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
    US-7351389-B2April 01, 2008Bracco International B.V.Aminocarboxylate ligands having substituted aromatic amide moieties
    US-5130120-AJuly 14, 1992Mallinckrodt Medical, Inc.Paramagnetic DTPA and EDTA alkoxyalkylamide complexes as MRI agents
    US-5811077-ASeptember 22, 1998Nihon Medi-Physics Co., Ltd.Method of NMR imaging
    US-5733528-AMarch 31, 1998Dibra S.P.A.Paramagnetic chelates for nuclear magnetic resonance diagnosis
    US-5985244-ANovember 16, 1999Imarx Pharmaceutical Corp.Polymers with a gas magnetic resonance imaging
    US-2007020185-A1January 25, 2007Epix Pharmaceuticals, Inc. A Delaware CorporationDiagnostic imaging contrast agents with extended blood retention
    US-5368840-ANovember 29, 1994Imarx Pharmaceutical Corp.Natural polymers as contrast media for magnetic resonance imaging
    US-5230883-AJuly 27, 1993Wisconsin Alumni Research FoundationMethod for localization and treatment of tumors using polylysine complexes
    US-5428155-AJune 27, 1995Board Of Regents, The University Of Texas SystemSynthesis of polyazamacrocycles with more than one type of side-chain chelating groups
    US-5750660-AMay 12, 1998The Dow Chemical CompanyBicyclopolyazamacrocyclophosphonic acid half esters
    US-5366722-ANovember 22, 1994Nycomed Imaging AsContrast media comprising a non-ionic contrast agent and sodium ions
    US-5932188-AAugust 03, 1999Sterling Winthrop Inc.Therapeutic and diagnostic imaging compositions and methods
    US-6576222-B2June 10, 2003Schering AktiengesellschaftCascade polymer bound complexing compounds, their complexes and conjugates, process for their production and pharmaceutical agents containing them
    US-5614170-AMarch 25, 1997Hemagen/PfcParamagnetic complexes of N-alkyl-N-hydroxylamides of organic acids and emulsions containing same for magnetic resonance imaging (MRI)
    US-5188816-AFebruary 23, 1993Board Of Regents, The University Of Texas SystemUsing polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS
    US-5681542-AOctober 28, 1997Imarx Pharmaceutical Corp.Compositions comprising a biocompatible gas and a polymer for magnetic resonance imaging
    US-5310535-AMay 10, 1994The Dow Chemical Company, The University Of TexasCarboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
    US-6054117-AApril 25, 2000Schering AktiengesellschaftCascade polymer bound complexing compounds, their complexes and conjugates, process for their production, and pharmaceutical agents containing them
    US-5650136-AJuly 22, 1997Schering AktiengesellschaftCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-5716598-AFebruary 10, 1998Nycomed Imaging AsContrast medium for magnetic resonance imaging using physiologically tolerable manganese compound
    WO-2012136813-A2October 11, 2012Universitetet I OsloAgents for medical radar diagnosis
    US-5658550-AAugust 19, 1997Imarx Pharmaceutical Corp.Non cross-linked synthetic polymers as contrast media for magnetic resonance imaging
    US-5155215-AOctober 13, 1992Access Pharmaceuticals Inc.Polychelating agents for image and spectral enhancement (and spectral shift)
    US-6248371-B1June 19, 2001Winthrop University HospitalMetal/thiol biocides
    US-5260050-ANovember 09, 1993Ranney David FMethods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
    US-2003180223-A1September 25, 2003Mcmurry Thomas J., Hironao Sijiki, Scott Daniel M., Lauffer Randall B.Diagnostic imaging contrast agents with extended blood retention
    US-2007020184-A1January 25, 2007Epix Pharmaceuticals, Inc. A Delaware CorporationDiagnostic imaging contrast agents with extended blood retention
    US-5458127-AOctober 17, 1995Imarx Pharmaceutical Corp.Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
    US-5630997-AMay 20, 1997Board Of Regents, The University Of Texas System, Dow Chemical CompanyPhosphorylated polyazamacrocyclic compounds for complexation of metal ions
    US-5274082-ADecember 28, 1993Nihon Medi-Physics Co., Ltd.Paramagnetic complexes of chelating compounds
    US-6193950-B1February 27, 2001Schering AgCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-5137711-AAugust 11, 1992Mallickrodt Medical, Inc.Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
    US-5863519-AJanuary 26, 1999Nycomed Imaging AsComposition and method of MRI using both a positive and a negative contrast agent
    US-5885548-AMarch 23, 1999Schering AktiengesellschaftMultiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents
    US-8017105-B2September 13, 2011Lantheus Medical Imaging, Inc.Diagnostic imaging contrast agents with extended blood retention
    US-5268165-ADecember 07, 1993Biomedical Frontiers, Inc.Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
    US-2011206606-A1August 25, 2011Bracco Imaging S.P.A.Stable radiopharmaceutical compositions and methods for preparation
    US-RE37793-EJuly 16, 2002Winthrop University HospitalMethod and composition for inhibiting bacteria
    US-5138039-AAugust 11, 1992Nihon Medi-Physics Co., LtdChelating compounds and their use
    US-6106866-AAugust 22, 2000Access Pharmaceuticals, Inc.In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
    US-5318771-AJune 07, 1994The General Hospital CorporationHydroxy-aryl metal chelates for diagnostic NMR imaging
    US-5385719-AJanuary 31, 1995Unger; Evan C., Wu; GuanliCopolymers and their use as contrast agents in magnetic resonance imaging and in other applications
    US-5316757-AMay 31, 1994Board Of Regents, The University Of Texas SystemSynthesis of polyazamacrocycles with more than one type of side-chain chelating groups
    US-5336762-AAugust 09, 1994Access Pharmaceuticals, Inc.Polychelating agents for image and spectral enhancement (and spectral shift)
    US-5645816-AJuly 08, 1997Imarx Pharmaceutical Corp.Synthetic polyuronic and hypoosmotic polymer compositions in admixture with proteinaceously bound contrast agents for MRI
    US-2004208827-A1October 21, 2004Epix Medical, Inc., A Delaware CorporationDiagnostic imaging contrast agents with extended blood retention
    US-8394356-B2March 12, 2013Lantheus Medical Imaging, Inc.Diagnostic imaging contrast agents with extended blood retention
    US-5676923-AOctober 14, 1997Schering AktiengesellschaftSubstituted DTPA monoamides of the central carboxylic acid group and their metal complexes
    US-5310539-AMay 10, 1994Board Of Regents, The University Of Texas SystemMelanin-based agents for image enhancement
    US-5928671-AJuly 27, 1999Winthrop University HospitalMethod and composition for inhibiting bacteria
    US-7229606-B2June 12, 2007Epix Pharmaceuticals, Inc.Diagnostic imaging contrast agents with extended blood retention
    US-5674470-AOctober 07, 1997Bracco Diagnostics Inc.Method for imaging mammalian tissue using 1-substituted- 4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
    US-5739323-AApril 14, 1998The Dow Chemical CompanyCarboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
    US-6125654-AOctober 03, 2000Syracuse UniversityBulk production and usage of hyperpolarized 129 Xenon
    US-5217998-AJune 08, 1993Biomedical Frontiers, Inc.Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
    US-6855309-B2February 15, 2005Schering, AgCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    WO-9616679-A1June 06, 1996Hemagen/PfcComplexes paramagnetiques de n-alkyl-n-hydroxylamides d'acides organiques et emulsions pour imagerie rmn les contenant
    US-5762910-AJune 09, 1998Imarx Pharmaceutical Corp.Liposoluble compounds useful as magnetic resonance imaging agents
    US-2003171561-A1September 11, 2003Pillai Radhakrishna K., Kang Sang I., Marinelli Edmund R., Ranganathan Ramachandran S., Tweedle Michael F.Aminocarboxylate ligands having substituted aromatic amide moieties
    US-6143274-ANovember 07, 2000Tweedle; Michael F., Gaughan; Glen T., Hagan; James J.Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
    US-5707604-AJanuary 13, 1998Access Pharmaceuticals, Inc.Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
    US-5463030-AOctober 31, 1995Research Foundation Of The State Of New YorkMetal chelating agents for medical application
    US-6875864-B2April 05, 2005Bracco International B.V.Aminocarboxylate ligands having substituted aromatic amide moieties
    US-5573752-ANovember 12, 1996Bracco International B.V.Aromatic amide compounds and metal chelates thereof
    US-5480990-AJanuary 02, 1996The Dow Chemical CompanyBicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
    US-5583206-ADecember 10, 1996Sterling WinthropChelating polymers
    US-5517993-AMay 21, 1996Imarx Pharmaceutical Corp.Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
    US-5672334-ASeptember 30, 1997Access Pharmaceuticals, Inc.Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
    US-5342606-AAugust 30, 1994Board Of Regents, The University Of Texas SystemPolyazamacrocyclic compounds for complexation of metal ions
    WO-9311800-A1June 24, 1993The Dow Chemical CompanyBicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
    US-5628982-AMay 13, 1997The General Hospital CorporationHydroxy-aryl metal chelates for diagnostic NMR imaging
    US-5846519-ADecember 08, 1998Bracco Diagnostics Inc.Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
    US-6086921-AJuly 11, 2000Wintrop-University HospitalMetal/thiol biocides
    US-5624662-AApril 29, 1997Imarx Pharmaceutical CorporationLiposoluble heterocyclic compounds useful as magnetic resonance imaging agents
    US-2007269375-A1November 22, 2007Bracco Imaging S.P.A.Stable Radiopharmaceutical Compositions and Methods for Preparation
    US-5679852-AOctober 21, 1997Schering AktiengesellschaftProcess for the production of DTPA-monoamides of the central carboxylic acid and their use as pharmaceutical agents
    US-5582814-ADecember 10, 1996Metasyn, Inc.1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
    US-5240693-AAugust 31, 1993University Of New MexicoImage enhancement by coadministration of biomodulators and structurally modified imaging agents
    US-2004202613-A1October 14, 2004Epix Medical, Inc., A Delaware CorporationDiagnostic imaging contrast agents with extended blood retention
    US-5474756-ADecember 12, 1995Bracco International B.V.Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
    US-7060250-B2June 13, 2006Epix Pharmaceuticals, Inc.Diagnostic imaging contrast agents with extended blood retention
    US-5213788-AMay 25, 1993Ranney David FPhysically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
    US-5250285-AOctober 05, 1993The General Hospital CorporationHydroxy-aryl metal chelates for diagnostic NMR imaging
    US-5527522-AJune 18, 1996The General Hospital CorporationHydroxy-aryl metal chelates for diagnostic NMR imaging
    US-2005090689-A1April 28, 2005Bracco International B.V.Aminocarboxylate ligands having substituted aromatic amide moieties
    WO-9533494-A1December 14, 1995Hemagen/PfcEmulsions d'agents de contraste paramagnetiques d'imagerie par resonance magnetique (mri) contenant un chelateur organique possedant un groupe aliphatique insature
    US-2003232017-A1December 18, 2003Johannes Platzek, Heribert Schmitt-Willich, Heinz Gries, Gabriele Schuhmann-Giampieri, Hubert Vogler, Hanns-Joachim Weinmann, Hans BauerCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-5817292-AOctober 06, 1998Nycomed Imaging AsMR imaging compositions and methods
    US-5328680-AJuly 12, 1994Nycomed Imaging AsContrast media comprising a non-ionic contrast agent with low levels of sodium & calcium ions
    US-5624661-AApril 29, 1997Unger; Evan C.Hypoosmotic compositions comprising a polymer and a complexed contrast agent for MRI
    US-7208139-B2April 24, 2007Schering AgCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-2005118105-A1June 02, 2005Johannes Platzek, Heribert Schmitt-Willich, Heinz Gries, Gabriele Schuhmann-Giampieri, Hubert Vogler, Hanns-Joachim Weinmann, Hans BauerCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-6183724-B1February 06, 2001Schering AktiengesellschaftCascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
    US-6676929-B2January 13, 2004Epix Medical, Inc.Diagnostic imaging contrast agents with extended blood retention
    US-2010129290-A1May 27, 2010I.S.T. CorporationSmart contrast agent and detection method for detecting transition metal ions
    US-7011815-B2March 14, 2006Epix Pharmaceuticals, Inc.Diagnostic imaging contrast agents with extended blood retention
    WO-9509563-A1April 13, 1995Arnon KrongradMethod for increasing nuclear magnetic resonance signals in living biological tissue
    US-RE36418-ENovember 30, 1999Nycomed Imaging AsContrast media comprising a non-ionic contrast agent with low levels of sodium and calcium ions
    US-5681544-AOctober 28, 1997Schering AktiengesellschaftPolymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them